Recent Buy ABBV

03 Jul 2018 22:48

Back to list of posts


Friday I started a small position in AbbVie (ABBV) by grabbing shares at a price of $92.93/share and a dividend yield of 4.13%. Pharmaceutical companies have been pressured for the last 6 weeks with some strong names like Johnson & Johnson (JNJ) and Pfizer (PFE) facing decreasing or stagnating share price.

All three companies (ABBV, JNJ, PFE) are currently decent buys and it is tough to choose. However, from a dividend growth perspective, you can’t go wrong with any of these three. I choose ABBV because I already have sizeable positions in JNJ, PFE, as well as Merck (MRK) which surprisingly has held up well over the last 6 weeks.

Comments: 2

Add a New Comment
or Sign in as Wikidot user
(will not be published)
- +

Unless otherwise stated, the content of this page is licensed under Creative Commons Attribution-ShareAlike 3.0 License